COMMUNIQUÉS West-GlobeNewswire

Spineway : First-quarter 2026 revenue
30/04/2026
Ecully, April 30, 2026 – 6:00 p.m. First-quarter 2026 revenue High order volume Slower-than-expected normalization of supply chains 2026: growth trajectory confirmed In thousands of euros 2026 2025 Change as a % Q1 [...]
TME Pharma publishes its annual financial results and annual report
30/04/2026
TME Pharma publishes its annual financial results and annual report Berlin, Germany , April 30, 2026, 20.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in [...]
TME PHARMA PUBLIE SES RÉSULTATS FINANCIERS ANNUELS ET SON RAPPORT ANNUEL
30/04/2026
TME PHARMA PUBLIE SES RÉSULTATS FINANCIERS ANNUELS ET SON RAPPORT ANNUEL Berlin, Allemagne, le 30 avril 2026, 20 h 00 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), Une société de biotechnologie en phase [...]
RAPPORT FINANCIER 2025
30/04/2026
RAPPORT FINANCIER 2025 Pièces jointes RAPPORT FINANCIER 2025 RAPPORT FINANCIER 2025
Sofanya Launches Highly Anticipated Sacred Body Oil Just in Time for Mother's Day: 'this isn't about doing more, it's about coming back'
30/04/2026
At the intersection of science and the Divine Feminine, Sofanya creates body care and wellness products that merge cellular nourishment with sacred ritual. Los Angeles, CA, April 30, 2026 (GLOBE NEWSWIRE) -- This Mother [...]
Ocubio Announces Appointment of Jim Mazzo and Dr. Eric Donnenfeld as Strategic Advisors
30/04/2026
MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- Ocubio, a biotechnology company advancing personalized, biologic-based therapies for ocular surface disease, today announced the appointment of James V. Mazzo and Eric D. [...]
KAI Conversations Announces Strategic Partnership with Syneos Health to Advance U.S. Pharmaceutical Commercialization
30/04/2026
AI-Driven Field Insights Drive Pharmaceutical Brand Performance in World’s Largest Market LONDON, April 30, 2026 (GLOBE NEWSWIRE) -- KAI Conversations, an AI-powered conversation intelligence platform purpose-built for [...]
Disclosure of transparency notification from BlackRock, Inc.
30/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 30 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/04/2026
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Dijon, France le 30 avril 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , société pharmaceutique spécialisée en phase avancée de développement et [...]
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
30/04/2026
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Dijon, France le 30 avril 2026 (17h45 CET) -- CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , société pharmaceutique spécialisée en phase avancée de développement et [...]
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
30/04/2026
Ghent, Belgium – April 30, 2026 – Confo Therapeutics , a leader in the development of medicines targeting G-protein coupled receptors (GPCRs), today announced that the first patients were dosed in a Phase 2a clinical [...]
Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results
30/04/2026
Press Release – No. 8 / 2026 Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results Copenhagen, Denmark and Boston, Massachusetts, April 30, 2026 – Zealand Pharma A/S [...]
SPINEWAY :
30/04/2026
Ecully, le 30 avril 2026 – 18h00 Chiffre d’affaires du 1er trimestre 2026 Niveau de commandes élevé Normalisation plus lente que prévue des approvisionnements 2026 : trajectoire de croissance confirmé En milliers d’ [...]
Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment
30/04/2026
Appointment signals next phase of expansion for HIFU-based prostate care as demand grows for non-invasive, function-preserving treatment options CHARLOTTE, N.C., April 30, 2026 (GLOBE NEWSWIRE) -- Sonablate, a medical [...]
FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
30/04/2026
Atrioventricular Interval Modulation (“AVIM”) Therapy Food and Drug Administration (“FDA”) Breakthrough Device Designations span the broader population of patients with uncontrolled hypertension despite medication at [...]
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
30/04/2026
— The new pricing structure is made available as of February for 12,67 PLN per day at pharmacies throughout Poland AMSTERDAM, April 30, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical [...]
Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting
30/04/2026
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]
Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
30/04/2026
In-Vivo Ovine Study Demonstrates Sustained Performance Of Company’s Continuous Blood Glucose Monitoring (CBGM) Technology Over 240 Days, Reinforces Path to Key IDE Submission RUTHERFORD, N.J., April 30, 2026 (GLOBE [...]
A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine
30/04/2026
Supports scientific development and laboratory testing to advance pharmacogenomics deployment across Japan TOKYO, April 30, 2026 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese corporate name: Genesis Healthcare [...]

Pages